Health care providers need to work together to ensure that high-risk individuals get the flu shot

NewsGuard 100/100 Score

Dr. Eric E. Whitaker, Illinois state public health director, is encouraging health care providers to work together to ensure that high-risk individuals get the flu shot.

“For most healthy people, influenza is uncomfortable but not a serious health threat,” Dr. Whitaker said. “But for some people, the flu could lead to serious complications or even death. Because of the currently limited vaccine supply, we need to work together to ensure the flu vaccine reaches those who are most at risk for complications.”

Local health departments are encouraged to reach out to their community partners and doctors’ offices to determine the availability of vaccine. Dr. Whitaker is also asking Illinois community groups and businesses that have purchased vaccine for low-risk individuals to defer these vaccinations and to notify their local health department about the supply. This will allow the local health departments to coordinate efforts to administer the flu vaccine to high-risk populations.

The Department is continuing to identify ways to protect as many high-risk Illinoisans as possible and will continue to consult with the U.S. Centers for Disease Control and Prevention to ensure quick response to any new developments.

Health officials were notified Tuesday by Chiron Corp. that none of its influenza vaccine would be available for distribution this flu season. Chiron Corp. was to produce between 46 million to 48 million doses of influenza vaccine for the United States this flu season. It is anticipated that 54 million doses of influenza vaccine from Aventis and another 1.1 million of FluMist nasal spray will be available.

High-risk individuals are encouraged to check on vaccine availability with their health care provider and, if no vaccine is available, to contact their local health department.

“The bulk of the vaccine supply is in the hands of physicians and other private health care providers, so that’s the best place to start,” Dr. Whitaker said. “High-risk individuals need to be persistent in trying to find vaccine.”

The influenza vaccine is 70 to 90 percent effective in preventing influenza among healthy adults 65 years of age or younger and those who do get ill will typically experience milder symptoms. People who are allergic to eggs, who have an acute illness with fever or who have previously had onset of Guillain-Barre syndrome during the six weeks after receiving influenza vaccine should check with their physician before getting the vaccine.

The flu season usually runs from November until April and often peaks between January and March. While October and November is the best time to be vaccinated, a flu shot can be given any time during the flu season.

Influenza, commonly called the flu, is caused by viruses that infect the respiratory tract and spreads from person to person when an infected person coughs or sneezes. Flu symptoms include fever (usually 100 degrees F in adults and often higher in children), dry cough, runny or stuffy nose, headache, muscle aches and extreme fatigue.

After a person has been infected with the virus, symptoms usually appear within one to four days. The infection is considered contagious for up to five days after symptoms appear and illness usually lingers for a week or two. Each year, an estimated 10 percent to 20 percent of the population contracts influenza.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows potential for universal flu vaccine with broad antibody response